Vanesa Nozal

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

Vanesa Nozal, Loreto Martínez‐González, Marta Gómez‐Almería et al. · Journal of Medicinal Chemistry · 2022 · 43 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

Tiziana Ginex, Urtzi Garaigorta, Victoria Castro et al. · Pharmaceuticals · 2021 · 42 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles

Elisa Rojas‐Prats, Carlota Tosat‐Bitrián, Loreto Martínez‐González et al. · Pharmaceutics · 2021 · 22 citations · Full text

Pharmacy, Neuroscience, Pharmacology +17

Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles

Vanesa Nozal, Elisa Rojas‐Prats, Inés Maestro et al. · International Journal of Molecular Sciences · 2021 · 22 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis

Vanesa Nozal, Alfonso García‐Rubia, Eva P. Cuevas et al. · Angewandte Chemie International Edition · 2021 · 20 citations · Full text

Life Sciences, Medicinal Chemistry, Neuroscience +17